TLDR: The Senate’s draft fiscal year 2027 spending bill keeps medical cannabis protections in place and leaves out the House committee’s proposed restriction on using federal funds to reschedule marijuana. The protection is a limit on Department of Justice spending, not an exemption from federal cannabis requirements, and it does not cover adult-use activity. The draft is a proposal prepared for markup, not a change in law.
On November 12, 2026, the Senate Appropriations Committee released its proposed fiscal year 2027 Commerce, Justice, Science, and Related Agencies funding bill. The proposal keeps medical cannabis protections in place and was part of a package of five spending bills released by the committee. Senate Appropriations Committee announcement
For cannabis businesses, two provisions stand out. The Senate draft retains the medical cannabis appropriations protection, and it leaves out the House committee’s proposed restriction on using federal funds to reschedule marijuana. Senate draft · House committee text, § 591
Medical cannabis protections remain in the draft
Section 531 would prohibit the Department of Justice from using funds made available under the bill to prevent the listed states and territories, including the District of Columbia, from implementing their laws authorizing the use, distribution, possession, or cultivation of medical marijuana. Senate draft, § 531, pp. 131-132
That is a restriction on specified federal spending, not a blanket exemption from federal cannabis requirements or an approval of a business’s DEA registration. The text concerns medical cannabis; it does not provide a general protection for adult-use activity. Senate draft, § 531
The House’s rescheduling restriction is absent
Section 591 of the House committee’s FY2027 bill would prohibit funds appropriated or otherwise made available by that legislation from being used to reschedule marijuana or remove it from the Controlled Substances Act’s schedules. House committee text, § 591, p. 147
The Senate draft contains no corresponding restriction. The omission is a difference between the proposals, not a congressional decision directing the DEA to reschedule marijuana. Senate draft bill text
The accompanying materials also address enforcement
The Senate’s explanatory statement acknowledges DOJ’s position that Section 531 does not explicitly prevent U.S. Attorneys’ Offices from enforcing 21 U.S.C. § 860, the federal drug-free school-zone provision. It also encourages DOJ to keep areas such as schools and playgrounds drug-free. This is language in the committee’s explanatory materials, not a newly enacted amendment to the statute. Senate explanatory statement, p. 96
The statement also calls for a DOJ report, coordinated with the DEA, the FBI, and the Executive Office for United States Attorneys, on illegal marijuana cultivation associated with foreign nationals. The report would assess possible links to Chinese transnational criminal organizations or the Chinese government and identify federal resources to support state, local, and tribal enforcement. The proposed deadline is 90 days after enactment, not 90 days after the draft’s release. Senate explanatory statement, pp. 96-97
This is a proposal, not a change in law
The Senate document identifies itself as a committee draft prepared for markup. Its release does not enact the proposed protections or resolve the differences with the House text. Senate draft, cover page
For medical cannabis businesses, the development is worth following because it concerns federal enforcement funding and a proposed obstacle to rescheduling. It should not be treated as a new DEA rule or permission to change operations.
Keep reading
Attorney advertising. General information only, not legal advice. Reading this article does not create an attorney-client relationship.
